Good afternoon, and thank you for joining the Inovio Fourth Quarter and Full Year 2025 Financial Results Conference Call.

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release ...

Compare four day trading simulator platforms that offer free and realistic practice, helping traders build skills and test ...

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 Earnings Call Transcript March 12, 2026 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $-0.358.

City head into tonight’s Champions League Round of 16 decider against Real Madrid with a mountain to climb in order to go ...

A coalition of advocates, scientists, and entertainers, including Penn & Teller and the American Psychological Association, ...

Cinematic worldbuilder Ashwin Gane links with Scott Storch and Kent Jones for “DND,” a chant‑ready late‑night anthem ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsJennie WillsonJacqueline Shea - CEO, President ...

Czechia lost to Korea in its first WBC matchup. Chung Sung-Jun / The Windup Newsletter ⚾ | This is The Athletic’s MLB ...

Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat ...

Noel Parks - Tuohy Brothers Investment Research, Inc. Siddharth Rajeev - Fundamental Research Corp. Greetings, and welcome to the Energy Vault's Fourth Quarter 2025 Earnings Call. [Operator ...

Since his first meeting in 2009, Mayo’s leader has always measured himself against the county of his parents.